Lv6
3200 积分 2022-11-23 加入
Mocertatug rezetecan (a B7-H4 targeted antibody drug conjugate) in patients with heavily pre-treated platinum-sensitive ovarian cancer (PSOC): results of an open label, phase 2 study
18天前
已完结
Mocertatug rezetecan, a B7-H4-targeted antibody-drug conjugate, in combination with bevacizumab in patients with platinum-sensitive ovarian cancer: results from a phase 1 study
19天前
已完结
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
1个月前
已完结
c-Met Expression Is a Marker of Poor Prognosis in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Chemoradiation
8个月前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
8个月前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
8个月前
已完结
EGFR expression in pancreatic adenocarcinoma. Relationship to tumour morphology and cell adhesion proteins
8个月前
已完结
Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours
8个月前
已完结
皖公网安备34019202002308
